Could a common drug stop stomach cancer before it starts?
Disease control
Recruiting now
This study tests whether the drug pyrvinium can reverse early changes in the stomach lining that may lead to cancer. About 32 adults with a high-risk precancerous condition called gastric intestinal metaplasia will receive either the drug or a placebo. The goal is to see if the d…
Phase: PHASE2 • Sponsor: Katherine Garman • Aim: Disease control
Last updated May 17, 2026 15:29 UTC